Jorge Hernando Cubero

510 total citations
11 papers, 166 citations indexed

About

Jorge Hernando Cubero is a scholar working on Oncology, Neurology and Epidemiology. According to data from OpenAlex, Jorge Hernando Cubero has authored 11 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Neurology and 5 papers in Epidemiology. Recurrent topics in Jorge Hernando Cubero's work include Lung Cancer Research Studies (6 papers), Neuroendocrine Tumor Research Advances (5 papers) and Neuroblastoma Research and Treatments (4 papers). Jorge Hernando Cubero is often cited by papers focused on Lung Cancer Research Studies (6 papers), Neuroendocrine Tumor Research Advances (5 papers) and Neuroblastoma Research and Treatments (4 papers). Jorge Hernando Cubero collaborates with scholars based in Spain, Palestinian Territory and Italy. Jorge Hernando Cubero's co-authors include Á. Artal, Javier Martínez‐Trufero, Roberto Pazo-Cid, Jaume Capdevila, Teresa Alonso Gordoa, Jaume Capdevila, Enrique Grande, A. Casado Herráez, Juan W. Valle and Vicent Fonollosa and has published in prestigious journals such as Annals of Oncology, Annals of the Rheumatic Diseases and Cancer Treatment Reviews.

In The Last Decade

Jorge Hernando Cubero

11 papers receiving 165 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jorge Hernando Cubero Spain 5 94 64 52 36 27 11 166
Alethia Álvarez‐Cano Mexico 6 70 0.7× 110 1.7× 54 1.0× 17 0.5× 25 0.9× 10 175
Alice Bonneville-Levard France 8 58 0.6× 23 0.4× 32 0.6× 22 0.6× 7 0.3× 15 142
Bérengère Dadone‐Montaudié France 7 73 0.8× 56 0.9× 14 0.3× 11 0.3× 14 0.5× 23 146
Céline Mahier - Aït Oukhatar France 8 74 0.8× 70 1.1× 38 0.7× 7 0.2× 14 0.5× 17 136
Daniele Alesini Italy 6 121 1.3× 57 0.9× 19 0.4× 13 0.4× 13 0.5× 18 184
Ivar Hompland Norway 8 187 2.0× 55 0.9× 19 0.4× 25 0.7× 12 0.4× 25 242
Maria A. Zarzour United States 9 145 1.5× 69 1.1× 54 1.0× 38 1.1× 65 2.4× 24 206
Helen Pasternack Germany 6 94 1.0× 79 1.2× 19 0.4× 18 0.5× 13 0.5× 11 193
David Marcilla Spain 7 61 0.6× 38 0.6× 44 0.8× 10 0.3× 19 0.7× 17 136
Weigang Guo China 9 104 1.1× 75 1.2× 50 1.0× 7 0.2× 25 0.9× 24 279

Countries citing papers authored by Jorge Hernando Cubero

Since Specialization
Citations

This map shows the geographic impact of Jorge Hernando Cubero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Hernando Cubero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Hernando Cubero more than expected).

Fields of papers citing papers by Jorge Hernando Cubero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Hernando Cubero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Hernando Cubero. The network helps show where Jorge Hernando Cubero may publish in the future.

Co-authorship network of co-authors of Jorge Hernando Cubero

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Hernando Cubero. A scholar is included among the top collaborators of Jorge Hernando Cubero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Hernando Cubero. Jorge Hernando Cubero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Cubero, Jorge Hernando, et al.. (2024). Maintenance therapy after first-line platinum-based chemotherapy in gastroenteropancreatic neuroendocrine carcinomas: A literature review. Cancer Treatment Reviews. 132. 102863–102863. 3 indexed citations
2.
Cubero, Jorge Hernando, et al.. (2022). What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?. Current Oncology Reports. 24(4). 451–461. 3 indexed citations
3.
Cubero, Jorge Hernando, et al.. (2021). Drug Development in Neuroendocrine Tumors: What Is on the Horizon?. Current Treatment Options in Oncology. 22(5). 43–43. 8 indexed citations
4.
5.
6.
Castillo, Alfredo, et al.. (2019). SAT0276 STUDY OF THE EPIDEMIOLOGICAL, CLINICAL AND ANALYTICAL CHARACTERISTICS IN PATIENTS WITH SYSTEMIC SCLEROSIS AND CANCER IN VALL D'HEBRON HOSPITAL. Annals of the Rheumatic Diseases. 78. 1214–1215. 1 indexed citations
7.
Cubero, Jorge Hernando, Alberto Carmona‐Bayonas, L. Iglesias, et al.. (2019). Durvalumab plus tremelimumab for the treatment of patients (pts) with refractory and progressive advanced thyroid carcinoma: A phase II multicohort trial (DUTHY / GETNE T1812). Annals of Oncology. 30. v759–v759. 4 indexed citations
8.
Martínez‐Trufero, Javier, et al.. (2017). Desmoid-Type Fibromatosis: Who, When, and How to Treat. Current Treatment Options in Oncology. 18(5). 29–29. 55 indexed citations
9.
Cubero, Jorge Hernando, et al.. (2015). Adenosquamous Cell Carcinoma of the Rectum in a Girl. Journal of Pediatric Hematology/Oncology. 37(6). e364–e367. 1 indexed citations
10.
Martínez‐Trufero, Javier, et al.. (2015). Gene expression profiling and its use in adenocarcinomas of unknown primary origin: A case report. Oncology Letters. 10(4). 2657–2661. 2 indexed citations
11.
Artal, Á., et al.. (2015). Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art.. PubMed. 4(2). 191–7. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alethia Álvarez‐Cano Breakdown of academic impact, for papers by Alice Bonneville-Levard Breakdown of academic impact, for papers by Bérengère Dadone‐Montaudié Breakdown of academic impact, for papers by Céline Mahier - Aït Oukhatar Breakdown of academic impact, for papers by Daniele Alesini Breakdown of academic impact, for papers by Ivar Hompland Breakdown of academic impact, for papers by Maria A. Zarzour Breakdown of academic impact, for papers by Helen Pasternack Breakdown of academic impact, for papers by David Marcilla Breakdown of academic impact, for papers by Weigang Guo
Rankless by CCL
2026